Herpes Zoster Onset 9 Years After First Varicella Zoster Vaccination in an 11-year-old Child - A Case Report

Author(s): Kerasia-Maria Plachouri*, Despoina Gkentzi, Anastasia Varvarigou, Sophia Georgiou, Gabriel Dimitriou

Journal Name: Current Pediatric Reviews

Volume 15 , Issue 4 , 2019


Become EABM
Become Reviewer
Call for Editor

Abstract:

Background: Herpes zoster (HZ) tends to affect the elderly population and immunocompromised younger patients. However, HZ cases in healthy children have also been reported.

Objective: This paper is a reminder to physicians, that Herpes Zoster can still be present in children, even in the era after the development of the varicella vaccine and its introduction in the national immunization programs globally.

Methods: We present the case of an immunocompetent 11-year old vaccinated male patient, who developed a HZ infection. The child had received two doses of the VZV vaccination (Varivax®), nine years (first dose) and six years (second dose) prior to the infection.

Results: Together with the case presentation, we summarize in this report the most recent published data, concerning the HZ prevalence in healthy varicella zoster vaccinated children.

Conclusion: Vaccinated pediatric patients are not completely free of risk concerning HZ. Physicians, especially pediatricians and dermatologists, should be alert in order to recognize and treat HZ early, so as to avoid further complications.

Keywords: Herpes zoster, vaccination, children, immunocompetent, varicella, complications.

[1]
Weinmann S, Chun C, Schmid DS, et al. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis 2013; 208(11): 1859-68.
[2]
Civen R, Marin M, Zhang J, et al. Update on incidence of herpes zoster among children and adolescents after implementation of varicella vaccination, antelope valley, CA, 2000 to 2010. Pediatr Infect Dis J 2016; 35(10): 1132-6.
[3]
Wutzler P, Casabona G, Cnops J, Akpo EIH, Safadi MAP. Herpes zoster in the context of varicella vaccination - An equation with several variables. Vaccine 2018; 36(46): 7072-82.
[4]
Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009; 28(11): 954-9.
[5]
Zoch-Lesniak B, Tolksdorf K, Siedler A. Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005-2016. Hum Vaccin Immunother 2018; 14(7): 1807-14.
[6]
Song H, Morley KW, Trowbridge RM, et al. Herpes zoster at the vaccination site in immunized healthy children. Pediatr Dermatol 2018; 35(2): 230-3.
[7]
Kim M, Juern AM, Paley S, Chiu YE. Vaccine-Associated Herpes Zoster. J Pediatr 2015; 167(2): 494.
[8]
Dagrosa AT, Collins LK, Chapman MS. Atypical herpes zoster presentation in a healthy vaccinated pediatric patient. Cutis 2017; 100(5): 303-4.
[9]
Scotta MC, Paternina-de la Ossa R, et al. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil. Vaccine 2018; 36(2): 280-4.
[10]
Komitova RT, Boykinova OB, Stoyanova NS. The skin and the eye - herpes zoster ophthalmicus in a healthy 18-month-old toddler. Folia Med 2018; 60(1): 170-4.


open access plus

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 4
Year: 2019
Published on: 30 December, 2019
Page: [265 - 267]
Pages: 3
DOI: 10.2174/1573396315666190318163927

Article Metrics

PDF: 23
HTML: 5